Aprepitant for refractory nivolumab-induced pruritus.

Ito, Jiro; Fujimoto, Daichi; Nakamura, Ayaka; Nagano, Tohru; Uehara, Keiichiro; Imai, Yukihiro; Tomii, Keisuke

Ito, Jiro; Fujimoto, Daichi; Nakamura, Ayaka; Nagano, Tohru; Uehara, Keiichiro; Imai, Yukihiro; Tomii, Keisuke.

Affiliation

Ito J; Department of Respiratory Medicine, Kobe City Medical Center General Hospital, Kobe, Hyogo, Japan. Electronic address: phyandeth69boo@gmail.com.
Fujimoto D; Department of Respiratory Medicine, Kobe City Medical Center General Hospital, Kobe, Hyogo, Japan.
Nakamura A; Department of Dermatology, Kobe City Medical Center General Hospital, Kobe, Hyogo, Japan.
Nagano T; Department of Dermatology, Kobe City Medical Center General Hospital, Kobe, Hyogo, Japan.
Uehara K; Department of Pathology, Kobe City Medical Center General Hospital, Kobe, Hyogo, Japan.
Imai Y; Department of Pathology, Kobe City Medical Center General Hospital, Kobe, Hyogo, Japan.
Tomii K; Department of Respiratory Medicine, Kobe City Medical Center General Hospital, Kobe, Hyogo, Japan.

Lung Cancer ; 109: 58-61, 2017 07.

Article in En | MEDLINE | ID: mdl-28577951

Subject(s)
Key words

ICIs; NK-1R; NSCLC; SJS; Stevens-Johnson syndrome; aprepitant; immune checkpoint inhibitors; immune-related adverse events; irAEs; neurokinin-1 receptor; nivolumab; non-small-cell lung cancer; pruritus

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pruritus / Morpholines / Stevens-Johnson Syndrome / Carcinoma, Non-Small-Cell Lung / Neurokinin-1 Receptor Antagonists / Immunotherapy / Lung Neoplasms / Antineoplastic Agents Type of study: Etiology_studies Limits: Aged / Female / Humans Country/Region as subject: Asia Language: En Journal: Lung Cancer Journal subject: NEOPLASIAS Year: 2017 Document type: Article

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google